Loading organizations...
§ Private Profile · Copenhagen, Hovedstaden, Denmark
Synthetic biology company producing cannabinoids for pharmaceuticals.
Octarine Bio has raised $13.7M across 4 funding rounds.
Octarine Bio has raised $13.7M in total across 4 funding rounds.
Octarine Bio has raised $13.7M across 4 funding rounds. Most recently, it raised $5.9M Series A Extension in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 23, 2026 | $5.9M Series A Plus | — | PER Falholt, Steen Riisgaard, Edaphon, Oskare Capital, Jonas AHM Lundgren, Unconventional Ventures | Announced |
| Nov 10, 2023 | $4.6M Venture Round | Oskare Capital, The Footprint Firm, Thea Messel | — | Announced |
| Sep 21, 2022 | $2M Seed Plus | Alexandre Ouimet Storrs | — | Announced |
| Mar 11, 2021 | $1.2M Seed Plus | Alexandre Ouimet Storrs, Lene Gerlach | — | Announced |
Octarine Bio has raised $13.7M in total across 4 funding rounds.
Octarine Bio's investors include Per Falholt, Steen Riisgaard, Edaphon, Oskare Capital, Jonas Ahm-Lundgren, Unconventional Ventures, The Footprint Firm, Thea Messel, Alexandre Ouimet-Storrs, Lene Gerlach.